Bosutinib, free base

Article number:


CAS No.:




Molecular weight:

530,45 g/mol

Bosutinib is an active inhibitor of Bcr-Abl in several chronic myelogenous leukemia cell lines. Bosutinib inhibits tumor cell proliferation, angiogenesis, growth factor expression in vivo. Bosutinib is a novel tyrosine kinase inhibitor.

Inform about
Bosutinib, free base

Protein Kinase Inhibitors

Protein kinases are enzymes that transfer phosphate groups from high-energy donors (typically nucleoside triphosphates) to surface exposed Serine, Threonine or Tyrosine side chains of other proteins and thus alter their ...

Read more